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Listeriosis is an emerging zoonotic infection of humans and ruminants worldwide caused by Listeria monocytogenes (LM).
In both host species, CNS disease accounts for the high mortality associated with listeriosis and includes rhombencephalitis,
whose neuropathology is strikingly similar in humans and ruminants. This review discusses the current knowledge about
listeric encephalitis, and involved host and bacterial factors. There is an urgent need to study the molecular mechanisms of
neuropathogenesis, which are poorly understood. Such studies will provide a basis for the development of new therapeutic
strategies that aim to prevent LM from invading the brain and spread within the CNS.
1. Introduction
The Gram-positive bacterium Listeria monocytogenes (LM)
was first isolated in a human patient with meningitis 1921
and subsequently worldwide from a wide range of mam-
malian and nonmammalian species, notably farm ruminants
[1–4]. However, it was not until the 1980s as a result of
several human epidemics that listeriosis was recognized as a
serious and frequently fatal foodborne disease and research
activity on the disease was substantially intensified [5–7].
Since then the incidence has risen steadily including large
outbreaks making listeriosis to a major public health issue
[8–12]. Clinical syndromes associated with LM infection
are similar in all susceptible hosts and include febrile gas-
troenteritis, septicemia, abortion, and central nervous system
(CNS) infections such as meningitis, meningoencephalitis,
and rhombencephalitis [11, 13, 14]. CNS involvement is a
characteristic feature and accounts for the high mortality
associated with listeriosis [11, 15, 16]. Currently, the agent
is one of the best-studied bacterial pathogens for various
reasons. Most importantly, it serves as model system for the
study of innate and cell-mediated immunity, host-pathogen
interactions, and intracellular survival of pathogens [17–
25]. More recently, the bacterium has been investigated
as a vector of heterologous proteins for vaccination and
immunotherapy of cancer and infectious diseases [26–30].
However, although much progress has been made in these
various fields of research, the pathogenesis and transmission
of the CNS infection in its natural hosts, most notably
the pathologically intriguing rhombencephalitis, is largely
unknown. Particularly, not much is known about bacterial
determinants that are associated with neurovirulence [31–
33]. The purpose of this review is to summarize the current
knowledge of the CNS form of LM infection in the natural
host.
2. Listeria monocytogenes: An Emerging
Foodborne Pathogen
LM belongs to the bacterial genus Listeria, which are Gram-
positive, nonspore-forming, facultatively anaerobic, and
intracellular coccobacilli. The genus comprises currently six
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species including LM, L. ivanovii, L. welschimeri, L. seeligeri,
L. grayi, and L. innocua [6]. Of those, only two species are
considered potentially pathogenic: LM and L. ivanovii [6].
LM is the major pathogen of listeriosis and the only species
of the genus that poses a serious public health risk. It causes
invasive and often fatal disease including CNS infection in
numerous animal species including farm ruminants, horses,
dogs, pigs, deer, South American camelids, cats, and men.
In contrast, L. ivanovii is considered only mildly pathogenic
and seems to affect almost exclusively ruminants, causing
abortion, still-births, and neonatal septicemia, but not CNS
infections [4, 6, 34]. Both LM and L. ivanovii hold a group
of virulence genes such as the positive regulatory factor A,
internalins, hemolysins, phospholipases, a hexose phosphate
transporter and others, which enable them to replicate within
and spread between eukaryotic cells [21, 35, 36]. These
virulence genes are absent or present in a nonfunctional form
in the other four Listeria species that are considered primarily
apathogenic saprophytes, although they have been very rarely
isolated from humans and animals [37–43]. Accordingly, this
review is confined to the discussion of LM.
LM is ubiquitously distributed and grows in a wide
variety of environments including soil, water, plant matter,
diverse food items, and intestinal tract of mammalian
hosts [6]. In addition, the bacterium has well adapted to
an intracellular life-cycle that is critical for its pathogenic
potential. LM is a biofilm-producer and as compared to
most other pathogenic bacteria relatively resistant to hostile
environmental conditions including low pH, high salt con-
centrations and low temperatures [3, 44–46]. These prop-
erties render LM remarkably tenacious against numerous
food-processing and food-preserving procedures and thus
hazardous for the food industry. Hence, the bacterium has
emerged as an important foodborne pathogen and is a major
cause for large food recalls due to bacterial contamination
[47, 48]. Although LM is able to infect a wide range of
animal species, it occurs primarily in farm ruminants and
humans [4, 14]. In both hosts, the prevalence of listeriosis
has risen significantly since the 1980s resulting in intensified
surveillance and control of LM in food industry, which
contributed to a decrease of human listeriosis cases in the
last two decades [49, 50]. However, in various European
countries its prevalence has again increased in the last few
years [9, 10, 51–53].
3. Listeriosis in Humans
3.1. Incidence. LM has been linked to sporadic episodes
as well as large outbreaks of human illness worldwide [7–
10, 12, 54–56]. The vast majority of human listeriosis cases
occurs following consumption of contaminated food [57].
Although relatively rare (the annual incidence rate ranges
from 1 to 10 cases per million), listeriosis has an important
impact on public health given that it is responsible for the
highest hospitalisation and mortality rates amongst food-
borne infections and LM is a common food contaminant
[15, 57, 58]. The case fatality rate ranges from 24% to 52%
despite adequate antimicrobial treatment [11, 15, 59–65].
3.2. Clinical Aspects. LM has the propensity to cause invasive
disease in well-defined risk groups including pregnant
women, individuals at the extremes of age (newborns or
elderly people), and patients with underlying conditions.
The list of such underlying conditions is long and includes
malignancies, diabetes mellitus, alcoholism, chronic hepatic
and renal diseases, organ transplantation, autoimmune dis-
eases, AIDS, immunosuppressive treatments (e.g., steroids),
and treatments reducing the gastric acid secretion [6, 11, 14,
15, 52, 59–62]. However, listeriosis can occur in otherwise
healthy individuals [8, 11].
The infection manifests in various syndromes, ranging
from mild febrile gastroenteritis to serious invasive disease
including septicaemia, abortions, and CNS disease [5, 6, 11].
In addition to these syndromes, listeriosis may present as
a local infection including dermatitis, endocarditis, peri-
carditis, pneumonia, peritonitis, arthritis, hepatitis, and
endophthalmitis [66–72]. Infection of nonpregnant adults
leads to bacteremia and CNS disease in most cases [11,
13, 65], and listeriosis is nowadays the second to fifth
most common etiology of human bacterial meningitis in
the Western hemisphere [15, 59–63, 73–79]. The CNS
form in humans generally develops as a diffuse meningi-
tis/meningoencephalitis, usually associated with bacteremia.
Meningitis prevails in neonates, elderly people and patients
with immunosuppressive disorders or other concurrent
conditions [11, 59, 60, 62, 74, 75, 80]. Less common
CNS manifestations include abscesses in the cerebrum or
cerebellum, and in up to 24% of patients encephalitis
targeting the brainstem (rhombencephalitis), but the latter is
probably under-recognized [13, 80–83]. Rhombencephalitis
has been first described in 1957 by Eck as an unusual form of
listeriosis [84]. In contrast to meningitis, it appears to occur
predominantly in previously healthy patients without any
predisposing conditions [13, 16, 82, 85]. The clinical course
is usually biphasic, with a prodrome of unspecific symptoms
consisting of headache, malaise, nausea, vomiting, and fever
in the first phase during between 4 and 10 days, followed
by progressive brainstem deficits with asymmetric cranial
nerves palsy, cerebellar dysfunctions, hemi- or tetraparesis,
sensory deficits, respiratory insufficiency, impairment of
consciousness, and sometimes seizures [13, 81, 82, 85].
Blood and spinal fluid cultures are positive in 60% and
40% of patients, respectively [81, 82]. The condition is fatal
unless treated early and survivors commonly have significant
neurological sequelae [14, 81].
3.3. Neuropathology. In most cases of human listeriosis,
the CNS form manifests as a diffuse suppurative menin-
gitis occasionally also extending into the ventricles [86].
Rhombencephalitis involves primarily the medulla oblon-
gata, pons and midbrain with infiltrates targeting frequently
nuclei and tracts of cranial nerves [85, 87]. Lesions may
extend into the cerebellum and further rostrally into the
thalamus and basal nuclei [87]. Cellular infiltrations consist
of agglomerates of microglial cells, microabscesses with
neutrophils and macrophages, occasionally accompanied by
neuronal necrosis and neuronophagia [87].
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4. Listeriosis in Ruminants
4.1. Incidence. Listeriosis is of major veterinary importance
in the three farm ruminant species cattle, sheep, and goats
[4], not only by virtue of significant economical losses in
livestock production due to morbidity and high mortality
in animals, but also with regard to food safety and public
health representing a possible link between the environment
and human infection.
In ruminants, the foodborne route of LM infection has
been well established long before it was shown in humans
[4]. Many studies have indicated that poor-quality silage is
commonly contaminated with LM and focused on spoiled
silage as source for listeriosis outbreaks [4, 88–105]. In line
with these results, fecal shedding of LM in cattle is associated
with contamination of silage [106, 107]. The investigation of
an epidemiological link between silage feeding and listeriosis
in ruminants, however, gave inconsistent results. Whilst
some studies could isolate matching LM strains in brains of
affected animals and silage samples, others yielded unrelated
strains [92, 94, 95, 98, 101, 108, 109]. A recent study detected
a higher prevalence of the bacterium in samples collected
from the immediate cattle environment (feed bunks, water
through and beddings) and in cattle feces than in silage
challenging the view that silage is the only source of LM
infection [92]. This finding is in line with reports and our
own observations of outbreaks unrelated to silage feeding
[110–113].
Recent prevalence estimates of listeric encephalitis in
cattle, sheep, and goats, based on neuropathological survey
studies in Europe, range between 7.5% and 29.4% and
a neuropathological survey of fallen stock in Switzerland
identified listeriosis as the most important CNS disease
of small ruminants [50, 114–117]. With reference to the
small ruminant population in Switzerland the prevalence
of listeric encephalitis was 216 cases/million sheep and 500
cases/million goats per year and thus exceeded significantly
the number of human cases (between 1.4 and 9 cases/million
inhabitants per year) [50, 58]. Similar data are not available
for bovines. However, in neuropathological surveillance
schemes for bovine spongiform encephalopathy in various
countries, listeriosis scores as the most frequent neurological
disease in cattle [114–117]. The importance of these data
is underlined by significant economical losses in life stock
industry caused by listeriosis, the likely role of ruminants
as reservoir for human pathogenic strains and therefore its
impact on food safety [118–121].
4.2. Clinical Aspects. The infection usually occurs in five dis-
tinct clinical presentations, of which encephalitis is by far the
most common form, followed by abortions, whilst neonatal
septicaemia, mastitis, and keratoconjunctivitis/uveitis occur
quite rarely [3, 4, 102, 122]. These syndromes seldom overlap
within the same animal or the same flock [4, 102, 123–127].
Some authors speculate that encephalitis occurs as a distinct
syndrome and more frequently than other clinical syndromes
in farm ruminants because immunity acquired through
ingestion of contaminated silage protects against septicemia
and abortion but is not fully effective in protection against
encephalitis [4]. Furthermore, ruminants may commonly be
asymptomatic intestinal carriers of the organism [90, 92,
128–130]. In contrast to humans, the classical CNS presen-
tation in ruminants is rhombencephalitis, whereas diffuse
meningitis or meningoencephalitis has only exceptionally
been reported [131]. Listeric rhombencephalitis was first
described in sheep as “circling disease” in New Zealand
and since then has been reported in all three ruminant
species around the world [4, 50, 98, 102, 105, 108, 111, 114,
125, 131–141]. Cattle appear to be less susceptible to the
infection than small ruminants [4]. Occasionally, listeriosis
may occur as an outbreak, particularly in sheep and goats
[101, 104, 111, 113, 125, 127] (and own observations). The
mortality rate is high despite antibiotic treatment [102].
Ruminants and in particular bovines are frequently exposed
to relatively high environmental levels of LM cells [92, 120].
As in humans, the disease usually has a low attack rate
affecting individual animals within a flock, although it is
assumed that all animals are exposed to a similar infectious
dose of LM [4, 102, 142, 143]. Therefore, most authors
speculate that—similar to the situation in humans—hitherto
unidentified underlying predisposing conditions facilitate
the development of clinical listeric disease. In agreement with
this hypothesis, cattle shed increased numbers of LM in their
feces after transport stress [106]. However, although some
authors described various concurrent conditions associated
with natural listeriosis, the existence of such predisposing
factors for listeric encephalitis has not yet been sufficiently
proven neither in epidemiological investigations nor in
experimental settings [4, 102, 111, 133, 144–155]. Further-
more, routine pathological examinations of ruminants with
listeric rhombencephalitis uncommonly reveal significant
concurrent disease (own observations). In this context, it
is intriguing that the majority of human rhombencephalitis
cases occurs in otherwise healthy individuals [82, 85, 156].
For unkown reasons, the incubation period for
encephalitis is longer compared to the other conditions
(septicaemia, abortion) and varies between 1 and 7 weeks
[4, 105, 157–159]. Clinical signs of listeric encephalitis are
similar in all three farm ruminants but vary depending
on the topography of the CNS lesions. Generally they
are characterized by unilateral or bilateral brainstem and
cranial nerve (CN) deficits [4, 148, 160–162]. Common
manifestations include masticatory problems, failure of jaw
closure, hypoalgesia of the head (involvement of CN V),
drooping of ears, upper eye lids and lips (involvement of
CN VII), deficits of the palpebral and menace reflex (CNs V
and VII), problems of swallowing (CNs IX and X), tongue
palsy (CN XII), circling, head tilt and leaning to one side
(vestibular system), nystagmus (CN VIII), and drooling of
saliva (Figures 1 and 2). Other more unspecific signs include
fever, dullness, and anorexia. In the terminal stage, animals
become recumbent and may show convulsions. Rare cases
have been described, in which limb paralysis occurred due to
affection of the spinal cord alone (myelitis) without involve-
ment of the brain [134, 163, 164]. The course of infection
in small ruminants (sheep and goats) is generally acute
and animals die within 1–3 days after clinical signs became
apparent. In cattle, the course is more prolonged [4, 158].
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Figure 1: Cow with rhombencephalitis due to Listeria monocyto-
genes infection. The cow has problems with swallowing (note the
feed below her head) and shows increased salivation, facial paralysis
with drooping of left ear and upper eyelid, courtesy of Dr. Mireille
Meylan, Vetsuisse Faculty, University of Bern.
4.3. Neuropathology. Gross lesions of the brain are generally
absent, but occasionally a greyish-tan discoloration and
malacia or simply hyperaemic vessels can be observed in the
brainstem. In contrast, histological lesions are pathognomic
for the disease and include a combination of suppurative
parenchymal lesions (microabscesses) and necrosis with
perivascular lymphohistiocytic cuffings and gliosis (Figures 3
and 4). In severe cases, microabscesses may coalesce to large
areas of suppuration. These changes are frequently accom-
panied by a meningitis. Lesions are commonly unilaterally
pronounced and centered on the medulla oblongata and
pons (Figure 3). However, they consistently spread rostrally
into the midbrain, diencephalons, and telencephalon and
caudally into the spinal cord [165]. Lesions in the rostral
brain show a consistent topography in selective fiber tracts.
The inflammatory process involves the ependyma and
choroid plexi only in exceptional cases and is then always
associated with rhombencephalitis [131, 165, 166].
5. Pathogenesis of Listeriosis and Key Virulence
Factors of L. monocytogenes
The pathogenicity of LM depends on its capacity to resist
hostile environmental conditions and invade and replicate in
both professional phagocytes and nonphagocytic host cells,
which is determined by at least 50 genes scattered in the
genome [22, 167]. Our knowledge of the pathogenesis at
the host and cellular level largely derives from infections in
various laboratory animals, notably the mouse, and in vitro
models.
5.1. Cellular Interactions. At the cellular level, the infection
cycle is regulated by the synchronized operation of various
virulence factors. The intracellular life cycle and the intercel-
lular spread of LM has been intensively studied revealing its
molecular adaptation to the intracellular microenvironment.
The reader is, therefore, referred to various reviews for
Figure 2: Recumbent goat with rhombencephalitis due to Listeria
monocytogenes infection. The animal has a head-tilt and pleurotho-
tonus; its right ear is drooping.
XII
RtF
Figure 3: Rhombencephalitis in a sheep: Brainstem at the obex
region with multiple microabscesses and perivascular cuffing
(arrowhead). Microabscesses involve the hypoglossal nucleus (XII),
its intracerebral root (arrows), and the reticular formation (RtF).
Hematoxylin & Eosin stain (H&E), bar = 740 μm.
Figure 4: Rhombencephalitis in a sheep: Microabscesses with
central bacterial colonies aligned along an axonal tract within the
reticular formation (medulla oblongata). H&E, bar = 100 μm.
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detailed information [17–19, 21, 168]. The invasion of the
host cell is mediated by interaction between internalins, lis-
teric surface ligands, and their respective host cell-receptors.
A large number of internalins and internalin-like proteins
have been identified by genome sequencing analysis of sev-
eral LM strains [18, 169–171] and the diversity of internalins
within the range of the different Listeria species and LM
strains could possibly explain the variation in virulence
and pathogenicity [172]. Amongst those, Internalin A and
B (InlA, InlB) are the best studied and these have been
detected only in LM so far [6, 173, 174]. The former
interacts with E-cadherin, which is mostly expressed on
epithelial cells in species-specific manner [175]. Notably, E-
cadherin is expressed on cells of three host barriers that
could determine the clinical syndromes: intestinal barrier,
blood-brain barrier, and placental barrier [176–179]. In
contrast, InlB promotes the invasion of a wide variety of
mammalian cells through interaction with three receptors:
Met, globular C1q receptor (gC1qR), and proteoglycans
[180–183]. Recently, other internalins, notably internalin
J, have been identified as key factors for virulence of LM
[184–190]. There is recent evidence that entry of LM into
the host cell requires additional factors such as clathrin-
mediated endocytosis [23, 191, 192]. Once within the cell,
LM is caught in a single-layer membrane phagocytic vacuole
and has to transiently resist phagosomal killing [193, 194].
The bacterium escapes from the phagosome and moves
into the host cell cytoplasm by employing a pore-forming
toxin, listeriolysin-O (LLO), assisted by two phospholipases,
phosphatidyl-inositol phospholipase C (PlcA) and phos-
phatidylcholine phospholipase C (PlcB) [195, 196]. Free in
the cytoplasm, LM replicates rapidly [197, 198]. A surface
protein of LM, Actin A (ActA), recruits host actin filaments
and induces their polymerization to a so-called actin comet
tail at one bacterial pole enabling the bacterium to move
freely within the cytoplasm and to spread to neighboring
cells by formation of cellular membrane protrusions that
are engulfed by adjacent cells [17]. The resulting secondary
double-membrane vacuole within the neighbor cell is lysed
by PlcB and LLO and a new infection cycle starts over
again [199]. It is believed that the direct intercellular spread
permits the bacterium to multiply and diffuse within tissues
protected from host defenses by avoiding the contact with the
extracellular compartement.
5.2. Infectious Process In Vivo. Whilst the different steps of
the intracellular infection cycle and key virulence factors
involved are well known [6, 18, 19, 21, 200], the knowledge
of the infectious process in vivo, notably in the natural host,
is currently limited. It is generally believed that LM enters
the host primarily through the intestine after oral intake of
contaminated food. In rare cases, direct skin exposure to LM,
for example, through contaminated abortive material, may
lead to cutaneous infections [201, 202]. Several virulence
factors enable LM to resist the exposure to a highly acidic
environment, proteolytic enzymes, and bile salts during its
gastroduodenal passage [44, 203–209]. Subsequently, LM
crosses the intestinal barrier by actively adhering to and
invading enterocytes through interactions between host-cell
receptors and internalins, namely, InlA [178]. After intestinal
translocation it invades the bloodstream and reaches liver
and spleen (primary target organs) hematogeneously. There,
resident hepatic and splenic macrophages kill the invading
bacteria leading to control of the infection [210]. This initial
step is thought to be subclinical and common due to the
high prevalence of LM in food. In normal individuals, such
exposure to listerial antigens probably contributes to the
maintenance of memorial T-cells [211]. The unrestricted
replication of LM in the primary target organs as it may
occur in immunocompromized individuals may result in
hematogenous dissemination to other organs and in overt
clinical disease. LM has a predilection for the placenta
and CNS (secondary target organs) that determines the
main clinical syndromes. This predilection is believed to
reflect the inherent ability of LM to cross the blood-
brain and the placental barrier, likely by the interaction of
bacterial internalins and their host cellular receptors [17, 21].
Recently, it has been shown that both InlA and B are required
for the crossing of the placenta [177, 212]. In contrast, such
an interaction remains to be shown to mediate the crossing
of the blood-brain barrier.
Much of the information reviewed above has been
derived from experimental work in laboratory rodents and
cell cultures, whereas the role of LM virulence factors in
its natural hosts is practically not known. InlA may play
a key-role in human virulence as it is indicated by an
epidemiological study, which detected a truncated form of
InlA in 35% of LM food isolates versus only 4% of clinical
isolates [213].
5.3. Genomic Organisation of Virulence Genes. The whole-
genome sequences of LM and of the related nonpathogenic
Listeria innocua and Listeria welshimeri have been deter-
mined, and their comparison has pioneered the identifica-
tion of virulence factors of LM [169, 170, 214–216]. Two
clusters of genes are required for the intracellular life-cycle
of LM. The genes that encode the key virulence factors
PlcA, LLO, ActA, and PlcB are clustered in a 10 kb virulence
locus on the chromosome, the Listeria pathogenicity island
1 (LIPI-1), and are under the control of a transcriptional
activator, the positive regulatory factor A (PrfA), [200, 217].
The latter itself is regulated by environmental conditions,
namely, the temperature [218–220]. At mammalian host
temperature (37◦C), PrfA is translated and thus PrfA-
dependent virulence genes are transcribed permitting LM to
switch from an environmental bacterium into a intracellular
pathogen. The second cluster consists of an operon with only
two genes, inlA and inlB. Additionally to inlA and inlB, a high
number of virulence genes encoding for internalin-like genes
are scattered within the genome [171].
6. Neuropathogenesis
The means by which LM invades the brain have been subject
of speculation for decades in both human and veterinary
medicine [4, 14, 221]. From the pathological point of view,
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the variation of neuropathological patterns that are associ-
ated with CNS infection suggests strongly that the pathogen
is able to invade the brain by both hematogenous spread
or by migration along axons. However, the pathogenesis
of both major manifestations of CNS infection—meningitis
and rhombencephalitis—is largely unknown. Notably, the
infectious dose required host and pathogen factors involved,
particularly the role of LM virulence factors, reasons for the
low attack rate, molecular mechanisms of brain invasion, and
dynamics of the CNS infection including factors determining
the outcome remain challenging.
6.1. Meningitis. The meningeal form with its diffuse
distribution—as it occurs frequently in humans—is likely
to be a result of hematogenous spread to the brain and
crossing of the blood brain barrier. Indeed, in murine
models of listeriosis bacteraemia is required for CNS invasion
and lesions as well as bacteria are mainly observed in
the meninges, choroid plexi and ependyme [222–225]. In
vitro and in vivo experiments could show that LM is
able to cross the blood-brain barrier by direct invasion of
endothelial cells, cell-to-cell spread from infected phagocytes
to endothelial cells, or by entry between endothelial cells
within infected phagocytes [222, 226–232]. At present,
the molecular mechanisms of breaching the blood-brain
barrier by LM are still virtually unknown. Given that the
endothelium and the choroid plexus epithelium of the
blood-brain barrier may express E-cadherin [179, 233–235],
some authors suggest that a receptor interaction between
the cellular E-cadherin and bacterial internalin A might be
the underlying mechanism of blood-brain-barrier crossing,
similar to what happens at the intestinal and placental
barrier [17, 21, 177, 212]. Epidemiologic data in humans
do not indicate that InlA contributes to neuroinvasion from
the bloodstream [213]. Two further virulence genes have
been proposed to play a role in CNS infection based on
investigations of mutant strains in the mouse model, plcB
and gtcA, a gene that mediates teichoic acid glycolisation.
PlcB is not indispensable, since plcB-negative mutants were
able to cause delayed encephalitis in the mouse-model [31].
Mutations involving the gtcA gene that encodes putative cell
wall components caused attenuated growth of LM in the
brain of mice, and thus the authors speculate that these
mutations caused a lower efficiency in the passage of the
blood-brain-barrier [32].
6.2. Rhombencephalitis in the Natural Host. In humans,
rhombencephalitis occurs in up to 24% of listeriosis patients
[13, 80–83]. Both distribution and nature of the lesions
are very similar in listeric rhombencephalitis of people and
ruminants [87, 165]. However, despite the significant losses
in livestock industry due to listeriosis and the growing
impact of this zoonosis in ruminants and humans [8, 9,
50], surprisingly few studies have been focused on the
pathogenesis of encephalitic disease in its natural hosts in
the last decades [33, 165, 236]. This is in contrast to the
large number of studies on listeric CNS disease in mice and
rats, which are not naturally susceptible to LM infection due
to species-specific properties of E-cadherin that functions
as a receptor for internalin A [31, 175, 222–225, 237–252].
Because experimental data and observations in natural dis-
ease diverge, the pathogenesis of listeric rhombencephalitis
and particularly the mechanisms of brainstem predilection
are still controversial [131, 135, 136, 166, 222, 253]. However,
the neuropathological pattern of the natural disease and
the observation of intraaxonal and intraneuronal bacteria
(Figures 5 and 6) strongly suggest that foodborne LM cells
invade the brainstem by axonal migration along various
cranial nerves [87, 131, 136, 165, 254]. Correspondingly, in
an outbreak of listeric myelitis in sheep ascending infection
via the sensory nerves following dermatitis was suspected
and subcutaneous injection of LM in the lumbar and
thoracic regions may cause lumbar and thoracic myelitis
in mice [163, 255]. These observations indicate that the
site of bacterial invasion determines the topography of
CNS lesions. Once in the brainstem, LM likely spreads
further rostrally to higher brain centers and caudally to
the spinal cord along axonal connections [165]. According
to this view, isolation of the agent from the cerebrospinal
fluid (CSF) in ruminant encephalitis usually fails indicating
that it rarely enters the CSF during infection [137]. The
intriguing topography of lesions that hit systematically
and particularly the rhombencephalon is atypical for a
bacterium. As a general rule, bacteria invade the brain
hematogenously. During septicemia, bacteria may cross the
blood-brain-barrier at the level of the microvasculature
causing meningitis, choroiditis, and ependymitis. Alterna-
tively, microorganisms may travel to the brain lodging in
septic thromboemboli that get trapped within parenchymal
vessels and produce disseminated suppurative lesions within
the brain parenchyma that with time develop to abscesses
[86]. In this context, it is fascinating that a second ubiq-
uitous and facultatively intracellular bacterium, which is
able to spread from cell to cell by actin-polymerization—
Burkholderia pseudomallei—causes a brainstem encephali-
tis in men and animals akin to that of LM [256–261].
Therefore, it is thought that Burkholderia pseudomallei like
LM probably moves to the brainstem by centripetal axonal
migration. Furthermore, in the vast majority of cases LM
is isolated from the brain, but not from other organs
[131, 158, 262]. Taken together, these data do not support
a hematogenous infection. LM rather enters submucosal
nerve endings through mucosal injuries anywhere in the
oropharyngeal and nasal cavity, lips, conjunctiva, or gut [135,
165]. It has been attempted to infect sheep using various
inoculation routes including intramuscular, intradermal,
subcutaneous, intracarotid, intracerebral, intravenous, oral,
intraruminal, intravaginal, and conjunctival inoculation
[133, 145–147, 152, 262–265]. However, typical lesions of
rhombencephalitis could only rarely be reproduced, and
clinical responses after the subcutaneous injection of LM
in sheep and goats or after oral challenge are generally
minimal [3, 133, 263, 265, 266]. In contrast, experimental
exposure of injured oral mucosa to LM and intranerval
inoculations may cause lesions in the brainstem of mice,
sheep and goats reminiscent of the natural disease [135, 157,
159, 237, 241, 267, 268]. Myelitis, and radiculitis in sheep
Interdisciplinary Perspectives on Infectious Diseases 7
∗
Figure 5: Rhombencephalitis in a sheep: necrotic neuron (asterisk)
with intraneuronal Listeria monocytogenes (arrow) in a microab-
scess of the medulla oblongata. H&E, bar = 13 μm.
Figure 6: Rhombencephalitis in a sheep: intraaxonal Listeria
monocytogenes (arrows) within a microabscess of the medulla
oblongata. H&E, bar = 13 μm.
were produced by injecting LM into the left infraorbital nerve
[269].
Some groups claim that hematogenous infection with
LM leads to rhombencephalitis, and targeting of the
brainstem is determined by its high microvascular density
[166, 222, 244, 270]. However, lesions were frequently not
restricted to rhombencephalitis, but included additional
severe and diffuse choroiditis, meningitis and disseminated
microabscesses in other brain areas, which is in contrast to
the natural disease.
6.3. Rhombencephalitis in Experimental Laboratory Animals.
Experimental research on listeric encephalitis, however,
yielded contradictory results. The main obstacle for the study
of listeric encephalitis is the lack of an animal or in vitro
model that reflects the natural infection and consistently
reproduces rhombencephalitis. Most experiments in labora-
tory rodents, notably the mouse, reflect unnatural infection
routes by employing intracerebral or intravenous infection,
as these species are highly resistant to lethal infection and
CNS invasion following oral inoculations of LM, which
imitate the natural route of infection, due to an amino acid
mutation in E-cadherin, the cellular receptor for InlA [175].
Although an increasing number of studies aim towards
natural routes of infection [176, 223], numerous studies
still employ parenteral inoculations. This problem may be
overcome in future with the use of the genetically engineered
E16P knock-in mouse that expresses human E-cadherin in
all tissues [271]. Animals inoculated intracerebrally or intra-
venously suffer a severe and diffuse meningoencephalitis and
choroiditis, but not rhombencephalitis [31, 222–225, 245–
247, 250, 251]. Differences in neuropathological expression
of CNS listeriosis between laboratory animals and the natural
host may not only reflect variation in exposure route but
also species-specific anatomical and physiological differences
of the brain. Furthermore, most experimental studies of
encephalitis in laboratory animals and cell cultures have been
carried out with the LM EGD strain and mutants, which are
serotype 1/2a and may not reflect the virulence mechanisms
of the other two clinically important serotypes 1/2b and
notably 4b [31, 32, 222, 239, 241, 242, 270, 272]. Therefore,
although laboratory animal models have contributed to
the understanding of the pathogenesis in listeriosis, the
results obtained in these models cannot be automatically
extrapolated to humans and ruminants, since small rodents
are not naturally susceptible to LM infection.
6.4. Mechanisms of Neural Spread. Although many data
strongly indicate a local invasion via centripetal migration
along axons, the mechanisms of this process are virtually
unknown. The first riddle to solve is how LM is able to
pass the mucosal barrier and enter the submucosal nerve
endings. At present, it is thought that LM passes the mucosal
epithelium of the upper gastrointestinal tract through small
mucosal abrasions. There are two potential scenarios that
may explain axonal invasion of cranial nerves: it may occur
when LM surface proteins interact with a yet unidentified
membrane receptor on the axonal surface or by cell-to-
cell spread from infected macrophages in the submucosa
[240]. The former hypothesis is supported by the apparently
selective infection of neuronal populations in vitro [239].
Potential candidates would be InlA and InlB, which have
both been shown to be required for the invasion of other
cell types [176–178, 180–183, 212]. Interestingly, the cellular
receptor of InlA, E-cadherin, is expressed in murine neuronal
subpopulations such as sensory neurons of the trigeminal
and dorsal root ganglion [273–275]. Most experimental data
favor an axonal invasion via cell-to-cell spread from infected
macrophages. In contrast to the observation of intraneuronal
and intraaxonal LM during natural encephalitis, in vitro data
of experimentally infected rat spinal and ovine brain cell
cultures indicate that the bacterium rarely infects neurons
[253, 276]. The infection rate increases when neurons are
cocultivated with infected macrophages, indicating that LM
infects neurons rather by cell-to-cell spread than by direct
invasion through receptor interaction [276]. Further evi-
dence for such a cell-to-cell spread of LM from macrophages
comes from in vivo data in mice indicating that macrophages
and dendritic cells facilitate neuroinvasion [272].
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The affection of both motor and sensory nerves indicates
that LM spreads by antero- and retrograde axonal migration
to the neuronal bodies of brainstem and midbrain, likely
by employing its actin tail as suggested by experimental
data [87, 165, 239, 240]. Transganglionic migration within
sensory nerves and further intracerebral spread between
functionally connected neuronal cell populations likely occur
via cell-to-cell spread. This would be in line with the
importance of PlcB, a virulence factor promoting cell-to-
cell spread, in the pathogenesis of experimental listeric
meningoencephalitis [31].
It is important to note that much of the information
reviewed above has been derived from experimental work in
laboratory rodents and cell cultures. Thus, it remains to be
demonstrated that these findings are applicable to the disease
in its natural hosts.
7. Strain Variation in Relation to
Neurovirulence in Humans and Ruminants
The species LM encompasses numerous strains and the
genetic diversity amongst them is high [277]. Various strains
have been implicated in both human and animal disease and
it is not clear which LM subtypes in the environment cause
illness. Thus, current surveillance schemes for foods are
based on the assumption that all LM isolates are potentially
pathogenic resulting in costly recalls in food industry.
However, epidemiological studies conjoint with strain sub-
typing by diverse methods (such as serotyping or genomic
approaches) suggest that there are, as yet, poorly understood
interstrain differences in virulence and transmission [120,
278–283]. Therefore, research in recent years focused on the
identification of molecular markers that determine the strain
variation in virulence. Although progress has been made,
the conundrum is only fragmentarily unraveled and with
regard to the neurological disease it is virtually unknown
whether neurotropic strains exist and what determines their
propensity for neuroinvasion.
7.1. Serotypes. Although at least 13 serotypes are known,
more than 95% of clinical isolates from human epidemics
or sporadic cases belong to only three serotypes: 1/2a, 1/2b,
and notably 4b, which are not the most common strains
amongst environmental and food isolates [213, 279, 281,
284–287]. On the other hand, other serotypes are rarely
responsible for human disease regardless of their common
isolation from food or environmental specimens [277, 282,
288, 289]. However, food strain types and clinical strains
partially overlap and key virulence genes are present in
all serotypes [118, 290–293]. Food isolates, though, show
more genetic diversity than clinical strains, suggesting that
only certain food-derived strains may cause human infection
[294]. The majority of LM strains that account for large
but temporally and geographically unrelated outbreaks of
food-borne listeriosis appear to form two epidemic clones
in the serotype 4b, independently of the contaminated
source involved [15, 279, 286, 295–297]. This serotype is
also responsible for the majority of sporadic infections and
is apparently overrepresented in pregnancy-associated cases
and meningoencephalitis, whilst 1/2b has been primarily
associated with nonpregnant individuals with severe under-
lying illness and HIV infections [279, 285, 298–301]. Taken
together, these data suggest that serotype 4b is more virulent
than other serotypes of LM. In line with these results, another
study revealed a higher mortality rate in patients infected
with strains of serogroup 4b as compared to other serotypes
[302].
7.2. Genotypes. The application of genomic subtyping meth-
ods resulted in two major evolutionary lineages (lineages
I and II) and one minor lineage (lineage III) of LM that
apparently differ in host specifity and pathogenic potential
[282, 283, 293, 297, 303–305]. Thereof lineage I is highly
clonal and contains all 4b food-borne-epidemic isolates
despite the different countries concerned and the food
vehicles involved as well as additional isolates from sporadic
cases. In contrast, lineage III contains no human clinical
isolates. Lineage II shows a greater genetic diversity and
contains clinical isolates but apparently no isolates from
food-borne epidemics. One study that employed repetitive
element sequence-based PCR could allocate food isolates in
another genomic cluster than clinical isolates from human
and animals [306].
7.3. Correlation of LM Strains with Pathogenicity. At present,
it is not known though whether the observed divergence
in subtype distribution between clinical and environmental
isolates reflects potential variation in virulence or adaptation
to particular ecological niches (e.g., food processing plants)
enabling certain serotypes to contaminate food products
at infectious levels [118]. One further explanation for the
divergence would be a transmission route different than
foodborne [289]. However, in either case a molecular basis
for variations remains to be discovered. First steps have been
done with the discovery of low-virulent strains that account
for a significant proportion of environmental isolates [278,
307–312]. Mutations in their key virulence genes including
inlA, inlB, plcB, prfA, hly (LLO-encoding gene), or actA
have been detected [313–317]. However, the low virulence is
mainly determined by point mutations in diverse virulence
genes, which are impossible to detect by most subtyping
methods [317]. Accordingly, attempts to use key virulence
proteins and genes as targets for discrimination of virulent
from avirulent LM strains generally failed because both pro-
teins and genes were present in the entire strain population
studied independently of their origin [282, 318–320]. An
exception is the low virulence of some strains determined
by a truncated form of InlA. An epidemiological study could
show that the full-length form of InlA was expressed by 96%
of clinical LM isolates versus 65% of food isolates [213, 313].
Internalin J (lmo 2821) is another virulence factor claimed to
be a putative marker for differentiation between virulent and
avirulent strains as it is invariably present in virulent strains
[184, 185, 321].
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As epidemiological data suggest interstrain variation in
virulence, strong efforts have been made to develop in
vitro tests and animal models that reflect the variation in
virulence between clinical and environmental strains, though
with inconsistent results. Although reproducible virulence
differences were observed between LM strains in both cell
cultures and animal models [278, 308–311, 322–326], not all
studies found a correlation of the virulence in the laboratory
with the serotype or the source (e.g., clinical isolate, food
isolate) [309, 327]. However, several mouse studies observed
a higher infectivity of serotypes 1/2a, 1/2b, 1/2c, and 4b
strains than other serotypes [184, 328–330] and some in
vitro studies observed virulence differences between clinical
and food isolates [307, 326, 331], which is in line with the
epidemiological observations.
7.4. L. monocytogenes Strains in Farm Animals. Although
little is known about the distribution of clinical LM strains
in animals, there is some epidemiological evidence that—
like in humans—interstrain differences in virulence and
organ tropism exist. In farm ruminants, the different clinical
forms rarely overlap in the same herd, and visceral and
cerebral listeriosis only exceptionally occur simultaneously
in the same animal [126, 282, 332]. Furthermore, LM
may cause encephalitis in pregnant ruminants without
inducing abortion [262, 333] (own observations). However,
the significance of divergent LM strains in the pathogenesis
of ruminant listeriosis is not well known. As in humans,
serovars 1/2a, 1/2b, and 4b appear to be the most commonly
isolated LM strains in ruminants and ruminant LM isolates
belong to all three identified evolutionary lineages [162, 282].
7.5. Factors of Neurovirulence. Whilst CNS infection is
substantially responsible for the high mortality in both
human and ruminant listeriosis, the identification of neu-
rovirulence factors has not received much attention. The
particular neuropathological pattern of rhombencephalitis
and the absence of other organs involvement in previously
healthy patients and ruminants suggests that LM strains
with neurotropism exist. But with regard to molecular
markers that determine strain variation in neuroinvasion and
neurovirulence research is in the dark. A major handicap is
the lack of an adequate animal or in vitro model to define and
measure neurovirulence.
Older publications describe that in natural ruminant
encephalitis either serotype 1 or 4b prevails depending on
the geographical area [158, 334]. In experimental infection
of sheep, one serotype 4 isolate showed high neurovirulence,
whilst serotype 1 did not induce rhombencephalitis [157].
Similar results have been reported by other authors [267,
268, 335, 336]. In this context, it is worthy of note that
occasionally different subtypes of LM may be isolated from
clinically affected animals during an outbreak [101, 110,
334]. Interestingly, a particular phage type of LM was associ-
ated with an unusually high incidence of rhombencephalitis
during a Swiss outbreak of human listeriosis [156].
PlcB has been proposed as a virulence factor for
encephalitis, but PlcB is not indispensable, since PlcB-
negative mutants were able to cause delayed encephalitis in
the mouse-model [31]. An epidemiological study of human
clinical isolates could associate CNS infections with two
particular ActA subtypes [287]. Wiedmann identified one
particular LM ribotype that was strongly associated with
encephalitis in cattle indicating that this ribotype might
be a host-associated subtype [282], and a recent study
suggests that lineage I strains may have neurotropism in
cattle [337]. These authors observed that encephalitic strains
in cattle posses a specific internalin profile (lacking inlF and
inlG) and a specific actA type (lacking one actA proline-
rich repeat) and therefore speculate that gene-loss events
and deletions may be associated with virulence and tissue
specificity of the different strains. However, the importance
of these genes in neurovirulence and neuroinvasion, whether
by hematogenous infection or axonal migration, is not
known.
8. Are Ruminants a Zoonotic Reservoir for
Human Rhombencephalitis Strains?
The link between ruminant and human listeriosis is not
completely understood. Listeriosis is defined a zoonosis,
but direct transmission between ruminants and humans
rarely occurs and is in most cases associated with nonlife-
threatening cutaneous infections through contact with
infected cattle or after handling of abortive material [201,
202]. However, it appears reasonable to implicate ruminants
as an important natural reservoir for strains causing human
infections given that one epidemic clone responsible for a sig-
nificant proportion of human epidemics has been frequently
isolated from cases of ruminant listeriosis [118, 121, 282, 297,
338]. Furthermore, dairy farms are frequently contaminated
with LM, particularly as compared to other environments,
and its subtype populations in the farm environment
encompass commonly strains that have been associated with
human illness, whether sporadic or epidemic [48, 90, 92, 107,
119, 120, 128, 139, 291, 339–345]. Ruminants, particularly
cattle, contribute to amplification and dispersal of LM into
the farm environment [120]. The bacteria can be shed in the
feces of clinically affected animals, but also healthy carriers
[90, 92, 107, 119, 128, 130, 339, 346, 347]. Raw milk might
contain LM either as a consequence of bacterial shedding in
the milk or due to exogenous contamination from the dairy
farm environment [291, 340, 348–355].
Human listeriosis is principally a food-borne infection
and most reported outbreaks of listeriosis in men are
attributed to the consumption of contaminated products
of animal origin [15, 58, 339, 340, 356–362]. Transmission
may occur indirectly through food products from infected
animals or healthy carriers that are not processed before
consumption as well as raw vegetables that are contaminated
by LM containing manure [363]. Most foods of animal
origin are treated by procedures that effectively kill LM in
raw foods. Therefore, a possible means of transmission of
LM strains from ruminants to humans is their introduction
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and establishment in food processing facilities, and their
ability to produce biofilms and to adhere to inert surfaces
may significantly contribute to the latter [46, 364, 365].
Supporting this hypothesis, one study identified several
LM genotypes that contaminated both dairy-processing and
farm environments [366].
Although all these results strongly implicate ruminants
as a natural reservoir for LM and a source of human
infections, at present, there are no data with regard to the
extent of strain population overlap between human and
ruminant rhombencephalitis. The identical neuropathology
of listeric rhombencephalitis in humans and ruminants,
however, indicates that neurotropic strains common to both
hosts are responsible for the disease.
9. Conclusions
Rhombencephalitis is an apparently uncommon form of
listeriosis in humans, but its prevalence is likely underesti-
mated [13, 80–83]. In contrast, in ruminants it is the most
common clinical expression of listeriosis and at the same
time the most common CNS disorder [50]. The intriguing
distribution and the nature of the lesions are very similar
in listeric rhombencephalitis of people and ruminants [87,
165]. Furthermore, ruminants may shed high numbers of
LM in their feces [90, 92, 107, 119, 128, 130, 339, 346,
347], and dairy farms are frequently contaminated [92, 120].
Until recently, it has been believed that all LM strains are
potentially pathogenic. However, epidemiological evidence
suggests that there are strain-specific variations in virulence
and research has identified strain variation in respect to
virulence in animal and cell culture models, although the
results frequently do not correlate with epidemiological
data. Taken together, these data indicate that neurotropic
strains of LM common to both humans and ruminants
might cause the rhombencephalitis and that ruminants and
their close environment may be their natural reservoir. The
identification of virulent strains causing rhombencephalitis
and their differentiation from avirulent and low-virulent
strains would help to implement effective control and
prevention measures against LM. In the context of the
reported increase of LM infections in humans [8–10] and the
high prevalence of listeric rhombencephalitis in ruminants
[50] there is an urgent need to study host and bacterial
factors, which contribute to listeric rhombencephalitis, and
notably the molecular mechanisms of neuroinvasion, which
are poorly understood. Future research might focus on the
identification of candidate bacterial proteins and the respec-
tive host cell receptors that determine host cell specificity and
tissue tropism. The first steps have been done by identifying
the key-players in the crossing of the intestinal and placental
barrier. Now it is time to search for those that enable the
agent to invade the brain.
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